Late bioprosthetic mitral valve thrombosis: a link with postoperative heparin-induced thrombocytopenia?
Bioprosthetic valve thrombosis is considered extremely unlikely, thus usually allowing patients to avoid long-term anticoagulation. The authors report the case of a patient with late bioprosthetic mitral valve thrombosis associated with a history of postoperative heparin-induced thrombocytopenia. The patient successfully underwent mitral valve replacement.
Bouallal
Rachid
R
Centre Hospitalier Régional et Universitaire de Lille, Department of Cardiology, Université de Lille 2, Faculté de Médecine, Lille, France.
Montaigne
David
D
Fayad
George
G
Auffray
Jean Luc
JL
Asseman
Philippe
P
Ennezat
Pierre Vladimir
PV
D000925:Anticoagulants / Q000009:adverse effects*; D001705:Bioprosthesis; D017023:Coronary Angiography; D003328:Coronary Thrombosis / Q000000981:diagnostic imaging / Q000209:etiology*; D004452:Echocardiography / Q000379:methods; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve; D008944:Mitral Valve Insufficiency / Q000209:etiology / Q000601:surgery*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000150:complications*
D000925:Anticoagulants; D006493:Heparin